Pub Date : 2025-07-17DOI: 10.1016/j.vaa.2025.07.005
André Escobar , Brighton T. Dzikiti , Kurt Roman , Alexandria Rogers , Jill K. Maney
Objective
To assess the effects of two continuous intravenous (IV) infusion dose rates of ketamine on the minimum anesthetic concentration (MAC) of isoflurane in chickens.
A group of eight adult ISA Brown hens weighing 2.1 ± 0.19 kg.
Methods
Anesthesia was induced and maintained with isoflurane in oxygen and chickens were mechanically ventilated. Body temperature and partial pressure of end-expired carbon dioxide were maintained between 40 and 41 °C and 30 and 40 mmHg (4–5.3 kPa). Isoflurane MAC was determined using electrical stimulation and the bracketing technique. Subsequently, a bolus of low (LD) or high (HD) dose ketamine (5 or 10 mg kg−1 IV) was injected into the brachial vein followed by a constant rate IV infusion (5 or 10 mg kg−1 hour−1, respectively), with a 1 week washout period between treatments. Isoflurane MAC was determined again approximately 1.5 (T1.5) and 3 hours (T3) after bolus injections. Adverse events and time to extubation were recorded. Data analyses consisted of a mixed-effects model for repeated measures (MAC data).
Results
Isoflurane MAC was 1.51 ± 0.18% (mean ± standard deviation). Isoflurane MAC at T1.5 and T3 was 1.45 ± 0.16% and 1.53 ± 0.15% (LD) and 1.42 ± 0.24% and 1.46 ± 0.23% (HD). Isoflurane MAC values during LD [(T1.5) p = 0.857 and (T3) p = 0.995] and HD [(T1.5) p = 0.797 and (T3) p = 0.974] ketamine infusion were not different from baseline. Extubation times after isoflurane discontinuation was 12 ± 9 minutes for the LD and 14 ± 5 minutes for the HD treatment. Overall, four animals (both treatments) developed an obstructive mucous plug in the endotracheal tube.
Conclusions and clinical relevance
Ketamine did not change isoflurane MAC in chickens. Chickens anesthetized with isoflurane and ketamine should be monitored for endotracheal tube obstruction.
目的:探讨氯胺酮连续两次静脉注射剂量率对鸡异氟醚最低麻醉浓度(MAC)的影响。研究设计:前瞻性、随机、盲法、实验交叉设计。动物:一组8只成年ISA褐鸡,体重2.1±0.19公斤。方法:异氟醚诱导麻醉并维持麻醉,机械通气。体温和呼气末二氧化碳分压分别维持在40 ~ 41℃和30 ~ 40 mmHg (4 ~ 5.3 kPa)之间。采用电刺激法和包套法测定异氟醚的MAC。随后,将低(LD)或高(HD)剂量氯胺酮(5或10 mg kg-1 IV)注射到肱静脉,然后进行等速静脉输注(分别为5或10 mg kg-1小时-1),两次治疗之间有1周的洗脱期。异氟烷MAC在注射后约1.5 (T1.5)和3小时(T3)再次测定。记录不良事件及拔管时间。数据分析包括重复测量的混合效应模型(MAC数据)。结果:异氟烷MAC为1.51±0.18%(平均值±标准差)。T1.5和T3时异氟烷MAC分别为1.45±0.16%和1.53±0.15% (LD)和1.42±0.24%和1.46±0.23% (HD)。在LD [(T1.5) p = 0.857, (T3) p = 0.995]和HD [(T1.5) p = 0.797, (T3) p = 0.974]输注氯胺酮期间异氟烷MAC值与基线无差异。异氟醚停药后,LD拔管时间为12±9分钟,HD为14±5分钟。总的来说,4只动物(两种治疗方法)在气管内管中出现了阻塞性粘液堵塞。结论及临床意义:氯胺酮对鸡异氟醚MAC无影响。用异氟醚和氯胺酮麻醉的鸡应监测气管内管阻塞情况。
{"title":"Effects of ketamine on the minimum anesthetic concentration of isoflurane in chickens (Gallus gallus domesticus)","authors":"André Escobar , Brighton T. Dzikiti , Kurt Roman , Alexandria Rogers , Jill K. Maney","doi":"10.1016/j.vaa.2025.07.005","DOIUrl":"10.1016/j.vaa.2025.07.005","url":null,"abstract":"<div><h3>Objective</h3><div>To assess the effects of two continuous intravenous (IV) infusion dose rates of ketamine on the minimum anesthetic concentration (MAC) of isoflurane in chickens.</div></div><div><h3>Study design</h3><div>Prospective, randomized, blinded, experimental crossover design.</div></div><div><h3>Animals</h3><div>A group of eight adult ISA Brown hens weighing 2.1 ± 0.19 kg.</div></div><div><h3>Methods</h3><div>Anesthesia was induced and maintained with isoflurane in oxygen and chickens were mechanically ventilated. Body temperature and partial pressure of end-expired carbon dioxide were maintained between 40 and 41 °C and 30 and 40 mmHg (4–5.3 kPa). Isoflurane MAC was determined using electrical stimulation and the bracketing technique. Subsequently, a bolus of low (LD) or high (HD) dose ketamine (5 or 10 mg kg<sup>−1</sup> IV) was injected into the brachial vein followed by a constant rate IV infusion (5 or 10 mg kg<sup>−1</sup> hour<sup>−1</sup>, respectively), with a 1 week washout period between treatments. Isoflurane MAC was determined again approximately 1.5 (T1.5) and 3 hours (T3) after bolus injections. Adverse events and time to extubation were recorded. Data analyses consisted of a mixed-effects model for repeated measures (MAC data).</div></div><div><h3>Results</h3><div>Isoflurane MAC was 1.51 ± 0.18% (mean ± standard deviation). Isoflurane MAC at T1.5 and T3 was 1.45 ± 0.16% and 1.53 ± 0.15% (LD) and 1.42 ± 0.24% and 1.46 ± 0.23% (HD). Isoflurane MAC values during LD [(T1.5) <em>p</em> = 0.857 and (T3) <em>p</em> = 0.995] and HD [(T1.5) <em>p</em> = 0.797 and (T3) <em>p</em> = 0.974] ketamine infusion were not different from baseline. Extubation times after isoflurane discontinuation was 12 ± 9 minutes for the LD and 14 ± 5 minutes for the HD treatment. Overall, four animals (both treatments) developed an obstructive mucous plug in the endotracheal tube.</div></div><div><h3>Conclusions and clinical relevance</h3><div>Ketamine did not change isoflurane MAC in chickens. Chickens anesthetized with isoflurane and ketamine should be monitored for endotracheal tube obstruction.</div></div>","PeriodicalId":23626,"journal":{"name":"Veterinary anaesthesia and analgesia","volume":"52 6","pages":"Pages 786-793"},"PeriodicalIF":1.9,"publicationDate":"2025-07-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144790182","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
To quantify C-arm–registered radiation exposure during ultrasound- and fluoroscopy-guided spinal interventional pain management in dogs, and to measure operator-based radiation levels to identify discrepancies between delivered and received dose.
Study design
A retrospective observational study.
Animals
A total of 82 canine spinal interventional pain management procedures performed at a single referral institution.
Methods
Radiation data [dose–area product (Gy·cm2) and absorbed dose (mGy)] were collected from a mobile C-arm fluoroscopy system for procedures conducted from September 2020 to August 2024. Effective dose (mSv) was calculated using a standard conversion factor applied to dose–area product (Gy·cm2). Operator exposure was monitored via thermoluminescent dosimeters (TLDs) placed at chest level and at the C-arm arc. TLD readings were retrieved quarterly through the Public Health England/UK Health Security Agency databases. The Shapiro–Wilk test was used to assess normality, and data were expressed as median (minimum–maximum) or mean ± standard deviation, as appropriate.
Results
The median absorbed dose for all spinal interventions was 3.97 (0.07–25.8) mGy. The corresponding median dose–area product and effective dose was 0.63 (0.01–4.12) Gy·cm2 and 0.15 (0.002–0.95) mSv, respectively. Procedural radiation exposure lay near the lower end of reported human ranges and operator TLD readings remained below detection thresholds despite cumulative procedural doses exceeding these levels.
Conclusions and clinical relevance
Ultrasound- and fluoroscopy-guided spinal interventional pain management in dogs resulted in relatively low radiation exposure levels for both animals and operators. Incorporating ultrasound aligns with the ‘as low as reasonably achievable’ principle, helping reduce fluoroscopy time and associated risks. These findings support the development of targeted radiation safety protocols for veterinary interventional procedures and underscore the importance of continued operator training and dosimetry monitoring.
{"title":"Radiation exposure during ultrasound- and fluoroscopy-guided spinal interventional pain management procedures in dogs: a retrospective analysis in a single institution","authors":"Roger Medina-Serra , Eliseo Belda , Patricia López-Abradelo , Aurora Zoff , Sandra Sanchís-Mora","doi":"10.1016/j.vaa.2025.07.004","DOIUrl":"10.1016/j.vaa.2025.07.004","url":null,"abstract":"<div><h3>Objective</h3><div>To quantify C-arm–registered radiation exposure during ultrasound- and fluoroscopy-guided spinal interventional pain management in dogs, and to measure operator-based radiation levels to identify discrepancies between delivered and received dose.</div></div><div><h3>Study design</h3><div>A retrospective observational study.</div></div><div><h3>Animals</h3><div>A total of 82 canine spinal interventional pain management procedures performed at a single referral institution.</div></div><div><h3>Methods</h3><div>Radiation data [dose–area product (Gy·cm<sup>2</sup>) and absorbed dose (mGy)] were collected from a mobile C-arm fluoroscopy system for procedures conducted from September 2020 to August 2024. Effective dose (mSv) was calculated using a standard conversion factor applied to dose–area product (Gy·cm<sup>2</sup>). Operator exposure was monitored via thermoluminescent dosimeters (TLDs) placed at chest level and at the C-arm arc. TLD readings were retrieved quarterly through the Public Health England/UK Health Security Agency databases. The Shapiro–Wilk test was used to assess normality, and data were expressed as median (minimum–maximum) or mean ± standard deviation, as appropriate.</div></div><div><h3>Results</h3><div>The median absorbed dose for all spinal interventions was 3.97 (0.07–25.8) mGy. The corresponding median dose–area product and effective dose was 0.63 (0.01–4.12) Gy·cm<sup>2</sup> and 0.15 (0.002–0.95) mSv, respectively. Procedural radiation exposure lay near the lower end of reported human ranges and operator TLD readings remained below detection thresholds despite cumulative procedural doses exceeding these levels.</div></div><div><h3>Conclusions and clinical relevance</h3><div>Ultrasound- and fluoroscopy-guided spinal interventional pain management in dogs resulted in relatively low radiation exposure levels for both animals and operators. Incorporating ultrasound aligns with the ‘as low as reasonably achievable’ principle, helping reduce fluoroscopy time and associated risks. These findings support the development of targeted radiation safety protocols for veterinary interventional procedures and underscore the importance of continued operator training and dosimetry monitoring.</div></div>","PeriodicalId":23626,"journal":{"name":"Veterinary anaesthesia and analgesia","volume":"52 6","pages":"Pages 894-898"},"PeriodicalIF":1.9,"publicationDate":"2025-07-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145016233","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-07-10DOI: 10.1016/j.vaa.2025.07.003
Minha Kim, Taehoon Sung, Changhoon Nam, Inhyung Lee, Won-gyun Son
Objective
To evaluate correlation between postanesthetic induction ratio of arterial partial pressure of oxygen to inspired oxygen fraction (PaO2:FIO2) and dynamic compliance (Cdyn) with postanesthetic hypoxemia [PaO2 < 80 mmHg (10.7 kPa)] in mechanically ventilated dogs, and to compare PaO2:FIO2 and Cdyn for predicting postanesthetic hypoxemia.
A total of 168 dogs anesthetized with isoflurane under pressure-controlled ventilation.
Methods
Postinduction arterial blood gas (ABG) analysis was performed 5–40 minutes postintubation and following postextubation (room-air). Cdyn values were matched to the nearest postinduction ABG measurement (within 15 minutes). PaO2:FIO2 and Cdyn values were categorized using thresholds of 300 mmHg (40.0 kPa) and 400 mmHg (53.3 kPa), and 1.0 and 1.5 mL cmH2O−1 kg-1. Linear-by-linear association was used to evaluate PaO2:FIO2 and Cdyn with the prevalence of postanesthetic hypoxemia. Diagnostic accuracy of these variables was assessed using receiver operating characteristic (ROC) curve analysis. Optimal cut-off values for distinguishing hypoxemia were determined using the empirical quantile bootstrap method (fixed sensitivity of 95%).
Results
Postanesthetic hypoxemia was observed in 22/168 dogs. Lower postinduction PaO2:FIO2 (p = 0.033) and Cdyn (p = 0.002) values were associated with a significantly higher prevalence of postanesthetic hypoxemia. The area under the ROC curve (AUC) of PaO2:FIO2 {0.696 [95% confidence interval (CI): 0.599–0.807]} and Cdyn [0.716 (95% CI 0.602–0.824)] exhibited good (AUC 0.6–0.7) to satisfactory (AUC 0.7–0.8) diagnostic accuracy, with no significant difference between variables (p = 0.432). Optimal cut-off values were 332.80 mmHg (44.4 kPa) (95% CI 274.41–374.52 mmHg, 36.6–49.9 kPa) for PaO2:FIO2 and 1.01 (95% CI 0.86–1.13) mL cmH2O−1 kg-1 for Cdyn.
Conclusions and clinical relevance
Postanesthetic hypoxemia was more frequently observed in dogs with low postinduction PaO2:FIO2 and Cdyn. These variables had good to satisfactory diagnostic accuracy.
{"title":"Evaluating the ratio of arterial partial pressure of oxygen to inspired oxygen fraction and dynamic compliance following anesthetic induction for predicting postanesthetic hypoxemia in dogs","authors":"Minha Kim, Taehoon Sung, Changhoon Nam, Inhyung Lee, Won-gyun Son","doi":"10.1016/j.vaa.2025.07.003","DOIUrl":"10.1016/j.vaa.2025.07.003","url":null,"abstract":"<div><h3>Objective</h3><div>To evaluate correlation between postanesthetic induction ratio of arterial partial pressure of oxygen to inspired oxygen fraction (PaO<sub>2</sub>:FIO<sub>2</sub>) and dynamic compliance (C<sub>dyn</sub>) with postanesthetic hypoxemia [PaO<sub>2</sub> < 80 mmHg (10.7 kPa)] in mechanically ventilated dogs, and to compare PaO<sub>2</sub>:FIO<sub>2</sub> and C<sub>dyn</sub> for predicting postanesthetic hypoxemia.</div></div><div><h3>Study design</h3><div>Retrospective, single-cohort, observational study.</div></div><div><h3>Animals</h3><div>A total of 168 dogs anesthetized with isoflurane under pressure-controlled ventilation.</div></div><div><h3>Methods</h3><div>Postinduction arterial blood gas (ABG) analysis was performed 5–40 minutes postintubation and following postextubation (room-air). C<sub>dyn</sub> values were matched to the nearest postinduction ABG measurement (within 15 minutes). PaO<sub>2</sub>:FIO<sub>2</sub> and C<sub>dyn</sub> values were categorized using thresholds of 300 mmHg (40.0 kPa) and 400 mmHg (53.3 kPa), and 1.0 and 1.5 mL cmH<sub>2</sub>O<sup>−1</sup> kg<sup>-1</sup>. Linear-by-linear association was used to evaluate PaO<sub>2</sub>:FIO<sub>2</sub> and C<sub>dyn</sub> with the prevalence of postanesthetic hypoxemia. Diagnostic accuracy of these variables was assessed using receiver operating characteristic (ROC) curve analysis. Optimal cut-off values for distinguishing hypoxemia were determined using the empirical quantile bootstrap method (fixed sensitivity of 95%).</div></div><div><h3>Results</h3><div>Postanesthetic hypoxemia was observed in 22/168 dogs. Lower postinduction PaO<sub>2</sub>:FIO<sub>2</sub> (<em>p</em> = 0.033) and C<sub>dyn</sub> (<em>p</em> = 0.002) values were associated with a significantly higher prevalence of postanesthetic hypoxemia. The area under the ROC curve (AUC) of PaO<sub>2</sub>:FIO<sub>2</sub> {0.696 [95% confidence interval (CI): 0.599–0.807]} and C<sub>dyn</sub> [0.716 (95% CI 0.602–0.824)] exhibited good (AUC 0.6–0.7) to satisfactory (AUC 0.7–0.8) diagnostic accuracy, with no significant difference between variables (<em>p</em> = 0.432). Optimal cut-off values were 332.80 mmHg (44.4 kPa) (95% CI 274.41–374.52 mmHg, 36.6–49.9 kPa) for PaO<sub>2</sub>:FIO<sub>2</sub> and 1.01 (95% CI 0.86–1.13) mL cmH<sub>2</sub>O<sup>−1</sup> kg<sup>-1</sup> for C<sub>dyn</sub>.</div></div><div><h3>Conclusions and clinical relevance</h3><div>Postanesthetic hypoxemia was more frequently observed in dogs with low postinduction PaO<sub>2</sub>:FIO<sub>2</sub> and C<sub>dyn</sub>. These variables had good to satisfactory diagnostic accuracy.</div></div>","PeriodicalId":23626,"journal":{"name":"Veterinary anaesthesia and analgesia","volume":"52 6","pages":"Pages 794-802"},"PeriodicalIF":1.9,"publicationDate":"2025-07-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144776292","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-07-04DOI: 10.1016/j.vaa.2025.06.012
Manuel Martin-Flores , Mark Rishniw
Objective
To examine the relationship between shortening fraction and ejection fraction, and to calculate the diagnostic performance of shortening fraction in identifying normal, subnormal and supranormal ejection fractions in dogs.
Study design
Reanalysis of prospective data.
Animal population
A group of 224 dogs; 86 healthy, 96 with mitral valve disease, and 42 with other cardiac pathologies.
Methods
Echocardiographic cineloops of right parasternal short- and long-axis (RPSA and RPLA) and left apical four-chamber (LA4C) views were analyzed by five experienced echocardiographers. Ejection fraction was measured using the Simpson’s method of discs from RPLA and LA4C, and shortening fraction from RPSA with M-mode. Sensitivity, specificity, and positive and negative predictive values of shortening fraction for identifying a low, normal, or high ejection fraction for each volumetric method, and the diagnostic performance of the LA4C volumetric method against the RPLA volumetric method, were calculated.
Results
Sensitivity and specificity to detect low ejection fraction were 92% and 93% (RPLA) and 71% and 91% (LA4C). The positive and negative predictive values for low ejection fraction were 55% and 99% (RPLA) and 46% and 97% (LA4C).
Conclusions and clinical relevance
Shortening fraction was a robust indicator of ejection fraction in dogs, with high sensitivity and specificity for the detection of decreased left ventricular systolic function. Given its simplicity and despite its limitations, shortening fraction might be a valuable tool during perianesthetic examinations of dogs.
{"title":"Relationship between ejection fraction and shortening fraction in dogs, and diagnostic accuracy of shortening fraction in identifying normal and abnormal ventricular contraction","authors":"Manuel Martin-Flores , Mark Rishniw","doi":"10.1016/j.vaa.2025.06.012","DOIUrl":"10.1016/j.vaa.2025.06.012","url":null,"abstract":"<div><h3>Objective</h3><div>To examine the relationship between shortening fraction and ejection fraction, and to calculate the diagnostic performance of shortening fraction in identifying normal, subnormal and supranormal ejection fractions in dogs.</div></div><div><h3>Study design</h3><div>Reanalysis of prospective data.</div></div><div><h3>Animal population</h3><div>A group of 224 dogs; 86 healthy, 96 with mitral valve disease, and 42 with other cardiac pathologies.</div></div><div><h3>Methods</h3><div>Echocardiographic cineloops of right parasternal short- and long-axis (RPSA and RPLA) and left apical four-chamber (LA4C) views were analyzed by five experienced echocardiographers. Ejection fraction was measured using the Simpson’s method of discs from RPLA and LA4C, and shortening fraction from RPSA with M-mode. Sensitivity, specificity, and positive and negative predictive values of shortening fraction for identifying a low, normal, or high ejection fraction for each volumetric method, and the diagnostic performance of the LA4C volumetric method against the RPLA volumetric method, were calculated.</div></div><div><h3>Results</h3><div>Sensitivity and specificity to detect low ejection fraction were 92% and 93% (RPLA) and 71% and 91% (LA4C). The positive and negative predictive values for low ejection fraction were 55% and 99% (RPLA) and 46% and 97% (LA4C).</div></div><div><h3>Conclusions and clinical relevance</h3><div>Shortening fraction was a robust indicator of ejection fraction in dogs, with high sensitivity and specificity for the detection of decreased left ventricular systolic function. Given its simplicity and despite its limitations, shortening fraction might be a valuable tool during perianesthetic examinations of dogs.</div></div>","PeriodicalId":23626,"journal":{"name":"Veterinary anaesthesia and analgesia","volume":"52 6","pages":"Pages 899-902"},"PeriodicalIF":1.9,"publicationDate":"2025-07-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144668623","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-07-03DOI: 10.1016/j.vaa.2025.06.010
Manuel Martin-Flores, Joaquin Araos, Robin D. Gleed
{"title":"Rocuronium and sugammadex in neonatal and juvenile foals","authors":"Manuel Martin-Flores, Joaquin Araos, Robin D. Gleed","doi":"10.1016/j.vaa.2025.06.010","DOIUrl":"10.1016/j.vaa.2025.06.010","url":null,"abstract":"","PeriodicalId":23626,"journal":{"name":"Veterinary anaesthesia and analgesia","volume":"52 6","pages":"Pages 962-963"},"PeriodicalIF":1.9,"publicationDate":"2025-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144668624","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-07-02DOI: 10.1016/j.vaa.2025.06.011
Noora Jantunen , Marja Raekallio , Bartlomiej Obrochta , Heidi Tapio , Luis Gracia Calvo , Rebecca Rivera Pöyhönen , Kati Hagman , Ninja Karikoski
Objective
To assess the effects of a 4 hour detomidine constant rate infusion (CRI) with and without a vatinoxan CRI on energy metabolism and urine composition.
Study design
Randomized, blinded, crossover study.
Animals
Eight Finnhorses, 587 (550–620) kg [median (range)] and 13 (4–16) years old.
Methods
Horses were administered an intravenous (IV) detomidine loading dose (0.01 mg kg-1) followed by 240 minutes CRI (0.015 mg kg-1 hour-1) (DET) and the same detomidine protocol combined with an IV vatinoxan loading dose (0.15 mg kg-1) and CRI (0.05 mg kg hour-1) (DET+VAT). Blood samples for glucose, insulin, non-esterified fatty acid (sNEFA), and β-hydroxybutyrate (sBHB) concentrations were collected during and for 240 minutes after CRI. Urine samples for glucose and sodium concentrations were collected at the end of CRI. Data were analysed using repeated measures ANCOVA and Wilcoxon signed-rank test.
Results
Blood glucose concentrations were significantly higher during CRI with DET compared with DET+VAT (all p < 0.001). Median insulin concentration was significantly lower during CRI with DET compared with DET+VAT (p = 0.012–0.018) and peaked at the end of follow-up period. With DET+VAT CRI, sBHB and sNEFA were significantly higher compared with DET (p < 0.001–0.002, p < 0.001–0.007). Urination was more frequent during DET CRI than with DET+VAT (p = 0.020). Glucosuria was more profound with DET [6.3 (2.4–11.1) mmol L-1] than with DET+VAT [0.1 (0.0–3.1) mmol L-1] (p = 0.012). More sodium was excreted into urine with DET [49.0 (22–66) mmol L-1] than with DET+VAT [27.0 (8–43) mmol L-1] (p = 0.012).
Conclusions and clinical relevance
Vatinoxan alleviated detomidine-induced hypoinsulinaemia and hyperglycaemia and diminished urination frequency, glucosuria, and natriuresis during and after a 4 hour CRI. Vatinoxan may be beneficial during standing sedation with alpha2-adrenoceptor agonists.
{"title":"The effects of a long-duration intravenous infusion of detomidine, with and without vatinoxan, on equine energy metabolism and urine composition","authors":"Noora Jantunen , Marja Raekallio , Bartlomiej Obrochta , Heidi Tapio , Luis Gracia Calvo , Rebecca Rivera Pöyhönen , Kati Hagman , Ninja Karikoski","doi":"10.1016/j.vaa.2025.06.011","DOIUrl":"10.1016/j.vaa.2025.06.011","url":null,"abstract":"<div><h3>Objective</h3><div>To assess the effects of a 4 hour detomidine constant rate infusion (CRI) with and without a vatinoxan CRI on energy metabolism and urine composition.</div></div><div><h3>Study design</h3><div>Randomized, blinded, crossover study.</div></div><div><h3>Animals</h3><div>Eight Finnhorses, 587 (550–620) kg [median (range)] and 13 (4–16) years old.</div></div><div><h3>Methods</h3><div>Horses were administered an intravenous (IV) detomidine loading dose (0.01 mg kg<sup>-1</sup>) followed by 240 minutes CRI (0.015 mg kg<sup>-1</sup> hour<sup>-1</sup>) (DET) and the same detomidine protocol combined with an IV vatinoxan loading dose (0.15 mg kg<sup>-1</sup>) and CRI (0.05 mg kg hour<sup>-1</sup>) (DET+VAT). Blood samples for glucose, insulin, non-esterified fatty acid (sNEFA), and β-hydroxybutyrate (sBHB) concentrations were collected during and for 240 minutes after CRI. Urine samples for glucose and sodium concentrations were collected at the end of CRI. Data were analysed using repeated measures ANCOVA and Wilcoxon signed-rank test.</div></div><div><h3>Results</h3><div>Blood glucose concentrations were significantly higher during CRI with DET compared with DET+VAT (all <em>p</em> < 0.001). Median insulin concentration was significantly lower during CRI with DET compared with DET+VAT (<em>p</em> = 0.012–0.018) and peaked at the end of follow-up period. With DET+VAT CRI, sBHB and sNEFA were significantly higher compared with DET (<em>p</em> < 0.001–0.002, <em>p</em> < 0.001–0.007). Urination was more frequent during DET CRI than with DET+VAT (<em>p</em> = 0.020). Glucosuria was more profound with DET [6.3 (2.4–11.1) mmol L<sup>-1</sup>] than with DET+VAT [0.1 (0.0–3.1) mmol L<sup>-1</sup>] (<em>p</em> = 0.012). More sodium was excreted into urine with DET [49.0 (22–66) mmol L<sup>-1</sup>] than with DET+VAT [27.0 (8–43) mmol L<sup>-1</sup>] (<em>p</em> = 0.012).</div></div><div><h3>Conclusions and clinical relevance</h3><div>Vatinoxan alleviated detomidine-induced hypoinsulinaemia and hyperglycaemia and diminished urination frequency, glucosuria, and natriuresis during and after a 4 hour CRI. Vatinoxan may be beneficial during standing sedation with alpha2-adrenoceptor agonists.</div></div>","PeriodicalId":23626,"journal":{"name":"Veterinary anaesthesia and analgesia","volume":"52 6","pages":"Pages 803-809"},"PeriodicalIF":1.9,"publicationDate":"2025-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144709025","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-06-26DOI: 10.1016/j.vaa.2025.06.009
Biancia Amiet , Joanne Rainger , Steven Zedler , Allison Stewart , Solomon Woldeyohannes , Wendy Goodwin
Objective
To compare horses’ aversive behavioural responses to the application of 5% prilocaine/lidocaine eutectic mixture of local anaesthetics (EMLA) cream versus subcutaneous infiltration of 2% lidocaine, followed by jugular vein catheterization.
Study design
Blinded, randomized study.
Animals
A group of 26 university-owned research horses.
Methods
Each horse received both treatments at opposite jugular sites with ≥ 12 hours between procedures. One randomly assigned jugular site received 1 g cm-2 of 5% EMLA cream 60 minutes before catheterization, while the contralateral site received 1.5 mL of 2% lidocaine subcutaneously 15 minutes prior. A 14 gauge catheter was introduced percutaneously and maintained for 20 minutes. A total of four blinded evaluators scored aversive behaviours during treatment application and catheterization using a simple descriptive scale (SDS). Treatment sites were assessed for erythema, blanching, or pain immediately after application and at 20 minutes and 24 hours post-catheter removal. Stratified multivariate Mann–Whitney U tests compared SDS values with significance at p < 0.05.
Results
Horses showed significantly lower SDS scores during EMLA application versus lidocaine injection (0.3 ± 0.3 and 0.5 ± 0.4, respectively; p = 0.012). However, during catheterization, horses treated with lidocaine had lower SDS scores than those treated with EMLA (0.4 ± 0.4 and 0.8 ± 0.5, respectively; p = 0.006), although this difference was not significant when corrected for catheter placement side (p = 0.077). Neither treatment caused adverse effects at application sites.
Conclusions and clinical relevance
The application of 5% EMLA cream was well tolerated in horses and may provide an alternative to subcutaneous infiltration of lidocaine prior to jugular vein catheterization in horses.
目的:比较5%普丙卡因/利多卡因共溶局部麻醉(EMLA)乳膏与2%利多卡因皮下浸润后颈静脉置管对马的厌恶行为反应。研究设计:盲法、随机研究。动物:一组26只大学拥有的研究用马。方法:每匹马在颈静脉相对部位接受两种治疗,疗程间隔≥12小时。一个随机指定的颈静脉部位在置管前60分钟接受1 g cm-2 5% EMLA乳膏,而对侧部位在置管前15分钟皮下接受1.5 mL 2%利多卡因。经皮引入14号导管并维持20分钟。共有四名盲法评估者使用简单描述性量表(SDS)对治疗应用和置管期间的厌恶行为进行评分。治疗部位在应用后立即、导管拔出后20分钟和24小时评估是否有红斑、焯水或疼痛。分层多变量Mann-Whitney U检验比较SDS值,p < 0.05为显著性。结果:与利多卡因注射组相比,EMLA组马的SDS评分显著降低(分别为0.3±0.3和0.5±0.4,p = 0.012)。然而,在置管期间,使用利多卡因治疗的马的SDS评分低于使用EMLA治疗的马(分别为0.4±0.4和0.8±0.5;p = 0.006),尽管在导管放置侧校正后这种差异不显着(p = 0.077)。两种治疗均未在应用部位产生不良反应。结论和临床意义:5% EMLA乳膏在马的耐受性良好,可能是在马颈静脉置管前皮下浸润利多卡因的替代方法。
{"title":"A comparison of a transdermal eutectic lidocaine/prilocaine cream and subcutaneous lidocaine injection prior to jugular vein catheterization in horses: a randomized crossover study","authors":"Biancia Amiet , Joanne Rainger , Steven Zedler , Allison Stewart , Solomon Woldeyohannes , Wendy Goodwin","doi":"10.1016/j.vaa.2025.06.009","DOIUrl":"10.1016/j.vaa.2025.06.009","url":null,"abstract":"<div><h3>Objective</h3><div>To compare horses’ aversive behavioural responses to the application of 5% prilocaine/lidocaine eutectic mixture of local anaesthetics (EMLA) cream <em>versus</em> subcutaneous infiltration of 2% lidocaine, followed by jugular vein catheterization.</div></div><div><h3>Study design</h3><div>Blinded, randomized study.</div></div><div><h3>Animals</h3><div>A group of 26 university-owned research horses.</div></div><div><h3>Methods</h3><div>Each horse received both treatments at opposite jugular sites with ≥ 12 hours between procedures. One randomly assigned jugular site received 1 g cm<sup>-2</sup> of 5% EMLA cream 60 minutes before catheterization, while the contralateral site received 1.5 mL of 2% lidocaine subcutaneously 15 minutes prior. A 14 gauge catheter was introduced percutaneously and maintained for 20 minutes. A total of four blinded evaluators scored aversive behaviours during treatment application and catheterization using a simple descriptive scale (SDS). Treatment sites were assessed for erythema, blanching, or pain immediately after application and at 20 minutes and 24 hours post-catheter removal. Stratified multivariate Mann–Whitney <em>U</em> tests compared SDS values with significance at <em>p</em> < 0.05.</div></div><div><h3>Results</h3><div>Horses showed significantly lower SDS scores during EMLA application <em>versus</em> lidocaine injection (0.3 ± 0.3 and 0.5 ± 0.4, respectively; <em>p</em> = 0.012). However, during catheterization, horses treated with lidocaine had lower SDS scores than those treated with EMLA (0.4 ± 0.4 and 0.8 ± 0.5, respectively; <em>p</em> = 0.006), although this difference was not significant when corrected for catheter placement side (<em>p</em> = 0.077). Neither treatment caused adverse effects at application sites.</div></div><div><h3>Conclusions and clinical relevance</h3><div>The application of 5% EMLA cream was well tolerated in horses and may provide an alternative to subcutaneous infiltration of lidocaine prior to jugular vein catheterization in horses.</div></div>","PeriodicalId":23626,"journal":{"name":"Veterinary anaesthesia and analgesia","volume":"52 6","pages":"Pages 933-940"},"PeriodicalIF":1.9,"publicationDate":"2025-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145034302","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-06-25DOI: 10.1016/j.vaa.2025.06.007
Caterina Vicenti , Marta Cercone , Gary Nieman , Nader M. Habashi , Penny Andrews , Joshua Satalin , Pamela Velarde , Katharyn J. Mitchell , Elizabeth Williams Louie , Victoria Albano , Haider Ali , Andrea King , Francesco Staffieri , Robin Gleed , Alex Bukoski , Klaus Hopster , David Hodgson , Andy Adler , Manuel Martin-Flores , Joaquin Araos
Objective
To compare early versus late time-controlled adaptive ventilation (TCAV) for setting airway pressure release ventilation (APRV) on arterial oxygenation in dorsally recumbent anesthetized horses.
Study design
A crossover, nonrandomized, experimental study.
Animals
Six healthy adult horses.
Methods
Each horse underwent two anesthetics: 1) volume-controlled ventilation (VCV) began for 30 minutes before switching to APRV using the TCAV method (late TCAV, TCAVL); and 2) ventilation began immediately with TCAV (early TCAV, TCAVE). The study lasted 180 minutes, with arterial blood gases and respiratory mechanics recorded at T0 and every 30 minutes. Electrical impedance tomography (EIT) was performed at T0, T30, T90 and T180 to calculate mid-cranial regional ventilation. A two-way repeated measures analysis of variance was used for comparisons. Lung ultrasound (LUS) images were obtained from three horses at baseline (before anesthesia) and at T30, T60, T120 and T180 during each crossover to calculate a mid-caudal LUS score. No statistical analysis was performed on ultrasound data.
Results
TCAVE showed significantly higher partial pressure of arterial oxygen to fraction of inspired oxygen (PaO2/FiO2) than TCAVL, whereas TCAV did not significantly affect it compared with VCV in the TCAVL group. TCAVE resulted in significantly higher tidal volumes (VT)than TCAVL, whereas in the TCAVL group, TCAV reduced VT compared with VCV. No significant differences were found in respiratory system compliance or airway driving pressure. Both TCAVE and TCAVL significantly improved dorsal lung ventilation on EIT, but TCAVL failed to reverse caudal atelectasis and consolidation seen on LUS, whereas TCAVE appeared to prevent it.
Conclusions and clinical relevance
TCAVE improved oxygenation and regional ventilation, whereas TCAVL failed to improve respiratory mechanics or oxygenation compared with VCV.
{"title":"Comparison of early and late time-controlled adaptive ventilation on pulmonary gas exchange in anesthetized horses","authors":"Caterina Vicenti , Marta Cercone , Gary Nieman , Nader M. Habashi , Penny Andrews , Joshua Satalin , Pamela Velarde , Katharyn J. Mitchell , Elizabeth Williams Louie , Victoria Albano , Haider Ali , Andrea King , Francesco Staffieri , Robin Gleed , Alex Bukoski , Klaus Hopster , David Hodgson , Andy Adler , Manuel Martin-Flores , Joaquin Araos","doi":"10.1016/j.vaa.2025.06.007","DOIUrl":"10.1016/j.vaa.2025.06.007","url":null,"abstract":"<div><h3>Objective</h3><div>To compare early <em>versus</em> late time-controlled adaptive ventilation (TCAV) for setting airway pressure release ventilation (APRV) on arterial oxygenation in dorsally recumbent anesthetized horses.</div></div><div><h3>Study design</h3><div>A crossover, nonrandomized, experimental study.</div></div><div><h3>Animals</h3><div>Six healthy adult horses.</div></div><div><h3>Methods</h3><div>Each horse underwent two anesthetics: 1) volume-controlled ventilation (VCV) began for 30 minutes before switching to APRV using the TCAV method (late TCAV, TCAV<sub>L</sub>); and 2) ventilation began immediately with TCAV (early TCAV, TCAV<sub>E</sub>). The study lasted 180 minutes, with arterial blood gases and respiratory mechanics recorded at T0 and every 30 minutes. Electrical impedance tomography (EIT) was performed at T0, T30, T90 and T180 to calculate mid-cranial regional ventilation. A two-way repeated measures analysis of variance was used for comparisons. Lung ultrasound (LUS) images were obtained from three horses at baseline (before anesthesia) and at T30, T60, T120 and T180 during each crossover to calculate a mid-caudal LUS score. No statistical analysis was performed on ultrasound data.</div></div><div><h3>Results</h3><div>TCAV<sub>E</sub> showed significantly higher partial pressure of arterial oxygen to fraction of inspired oxygen (PaO<sub>2</sub>/F<span>i</span>O<sub>2</sub>) than TCAV<sub>L</sub>, whereas TCAV did not significantly affect it compared with VCV in the TCAV<sub>L</sub> group. TCAV<sub>E</sub> resulted in significantly higher tidal volumes (V<sub>T</sub>)than TCAV<sub>L</sub>, whereas in the TCAV<sub>L</sub> group, TCAV reduced V<sub>T</sub> compared with VCV. No significant differences were found in respiratory system compliance or airway driving pressure. Both TCAV<sub>E</sub> and TCAV<sub>L</sub> significantly improved dorsal lung ventilation on EIT, but TCAV<sub>L</sub> failed to reverse caudal atelectasis and consolidation seen on LUS, whereas TCAV<sub>E</sub> appeared to prevent it.</div></div><div><h3>Conclusions and clinical relevance</h3><div>TCAV<sub>E</sub> improved oxygenation and regional ventilation, whereas TCAV<sub>L</sub> failed to improve respiratory mechanics or oxygenation compared with VCV.</div></div>","PeriodicalId":23626,"journal":{"name":"Veterinary anaesthesia and analgesia","volume":"52 6","pages":"Pages 810-820"},"PeriodicalIF":1.9,"publicationDate":"2025-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144709024","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
To evaluate the sedative and cardiovascular effects of premedication with acepromazine, methadone and dexmedetomidine or acepromazine and methadone in sevoflurane-anaesthetized dogs.
Study design
A randomized, blinded, prospective clinical study.
Animals
A total of 38 client-owned healthy dogs scheduled for elective surgery.
Methods
Dogs were randomly assigned to intramuscular premedication with acepromazine (0.01 mg kg-1), methadone (0.3 mg kg-1) and dexmedetomidine (1.5 μg kg-1) (Ace/D group) or with acepromazine (0.01 mg kg-1) and methadone (0.3 mg kg-1) (Ace group). The anaesthetist who performed the observations and anaesthesia was blinded to the group. Sedation was scored at 5, 10 and 15 minutes after premedication and postoperatively every hour until discharge, starting 30 minutes after extubation. Anaesthesia was induced with propofol and maintained with sevoflurane in oxygen and air. Body temperature, heart rate (HR), respiratory rate (fR), direct arterial blood pressure, end-tidal sevoflurane, end-tidal carbon dioxide (Pe´CO2) and oxygen saturation were recorded at 5 minute intervals. The normality of data distribution was assessed with the Shapiro–Wilk test. The Mann–Whitney U test was used for comparison between groups, and effect size was calculated in cases of statistical significance (p < 0.05).
Results
Dogs in the Ace/D group had significantly higher sedation scores 10 minutes after premedication (p = 0.02). The propofol induction doses were significantly lower in the Ace/D group (p = 0.001). During anaesthesia, dogs in the Ace/D group had significantly higher Pe´CO2 values (p = 0.03), but no significant differences in blood pressure, HR and fR were observed between the groups. Significantly fewer dogs in the Ace/D group required rescue analgesia with fentanyl (p = 0.04) during surgery (three in Ace/D and nine in Ace group).
Conclusions
Low-dose dexmedetomidine improved preoperative sedation and intraoperative analgesia and reduced the induction dose of propofol in dogs premedicated with acepromazine and methadone.
{"title":"Sedative and cardiovascular effects of premedication with acepromazine, methadone and dexmedetomidine in sevoflurane-anaesthetized dogs","authors":"Mihaela Klasić , Alenka Seliškar , Kristina Rakinić , Manica Ipavec , Jerneja Sredenšek , Katerina Tomsič","doi":"10.1016/j.vaa.2025.06.008","DOIUrl":"10.1016/j.vaa.2025.06.008","url":null,"abstract":"<div><h3>Objective</h3><div>To evaluate the sedative and cardiovascular effects of premedication with acepromazine, methadone and dexmedetomidine or acepromazine and methadone in sevoflurane-anaesthetized dogs.</div></div><div><h3>Study design</h3><div>A randomized, blinded, prospective clinical study.</div></div><div><h3>Animals</h3><div>A total of 38 client-owned healthy dogs scheduled for elective surgery.</div></div><div><h3>Methods</h3><div>Dogs were randomly assigned to intramuscular premedication with acepromazine (0.01 mg kg<sup>-1</sup>), methadone (0.3 mg kg<sup>-1</sup>) and dexmedetomidine (1.5 μg kg<sup>-1</sup>) (Ace/D group) or with acepromazine (0.01 mg kg<sup>-1</sup>) and methadone (0.3 mg kg<sup>-1</sup>) (Ace group). The anaesthetist who performed the observations and anaesthesia was blinded to the group. Sedation was scored at 5, 10 and 15 minutes after premedication and postoperatively every hour until discharge, starting 30 minutes after extubation. Anaesthesia was induced with propofol and maintained with sevoflurane in oxygen and air. Body temperature, heart rate (HR), respiratory rate (<em>f</em><sub>R</sub>), direct arterial blood pressure, end-tidal sevoflurane, end-tidal carbon dioxide (P<span>e</span>´CO<sub>2</sub>) and oxygen saturation were recorded at 5 minute intervals. The normality of data distribution was assessed with the Shapiro–Wilk test. The Mann–Whitney <em>U</em> test was used for comparison between groups, and effect size was calculated in cases of statistical significance (<em>p</em> < 0.05).</div></div><div><h3>Results</h3><div>Dogs in the Ace/D group had significantly higher sedation scores 10 minutes after premedication (<em>p</em> = 0.02). The propofol induction doses were significantly lower in the Ace/D group (<em>p</em> = 0.001). During anaesthesia, dogs in the Ace/D group had significantly higher P<span>e</span>´CO<sub>2</sub> values (<em>p</em> = 0.03), but no significant differences in blood pressure, HR and <em>f</em><sub>R</sub> were observed between the groups. Significantly fewer dogs in the Ace/D group required rescue analgesia with fentanyl (<em>p</em> = 0.04) during surgery (three in Ace/D and nine in Ace group).</div></div><div><h3>Conclusions</h3><div>Low-dose dexmedetomidine improved preoperative sedation and intraoperative analgesia and reduced the induction dose of propofol in dogs premedicated with acepromazine and methadone.</div></div>","PeriodicalId":23626,"journal":{"name":"Veterinary anaesthesia and analgesia","volume":"52 5","pages":"Pages 595-603"},"PeriodicalIF":1.9,"publicationDate":"2025-06-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144745085","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-06-19DOI: 10.1016/j.vaa.2025.06.006
Adalaïs Gibert , Ryota Watanabe , Marta Garbin , Tristan Juette , Francis Beaudry , Marion Desmarchelier , Inga-Catalina Cruz Benedetti
Objective
To evaluate the pharmacokinetics and pharmacodynamics of a single oral dose of trazodone in laboratory rabbits.
Study design
Randomised, blinded, Latin-square study.
Animals
A group of eight healthy, juvenile, female New Zealand White rabbits.
Methods
Auricular venous catheters were placed in six rabbits before oral trazodone (20 mg kg–1) administration. Blood was sampled immediately before and at 15 and 30 minutes and 1, 2, 4, 8, 12, 18 and 24 hours after treatment. Trazodone plasma concentrations were determined using high-performance liquid chromatography–mass spectrometry. A group of eight rabbits were equipped with accelerometers (activity) and video recorded. They randomly received one of three treatments: oral trazodone (20 mg kg–1; TRAZ), placebo (corn oil base; PLAC) or no treatment (CONTR) with a 3 day washout period between treatments. Exploring, grooming, resting, vigilance, hiding and ingesting behaviours were evaluated for 10 hours (0–2, 2–4, 4–6, 6–8 and 8–10 hours).
Results
Mean maximum plasma concentration, 6592.6 ± 586.5 ng mL–1, was 0.3 ± 0.11 hours after treatment. Mean half-life was 3.24 ± 0.36 hours and area under the curve from zero to infinity 25,412.5 ± 5420.9 ng mL–1 hour–1. Activity was higher in TRAZ and PLAC than CONTR at 0–2 hours, with TRAZ exploring more. Hiding was reduced in TRAZ versus CONTR (0–2 hours and 4–6 hours) and versus PLAC (0–6 hours). Resting increased in TRAZ versus PLAC (2–4 hours) and CONTR (4–6 hours); PLAC rested less at 2–4 hours than at 8–10 hours. Vigilance tended to be lower in TRAZ versus CONTR. Food intake decreased in TRAZ at 2–4 hours. Grooming varied over time.
Conclusions and clinical relevance
Trazodone-treated animals showed reduced activity, less hiding and more resting than PLAC and decreased food intake 2–4 hours post-treatment.
目的:评价单次口服曲唑酮在家兔体内的药动学和药效学。研究设计:随机、盲法、拉丁方研究。动物:一群8只健康的幼年雌性新西兰白兔。方法:6只家兔在口服曲唑酮(20mg kg-1)前放置耳静脉导管。在治疗前、15分钟和30分钟以及治疗后1、2、4、8、12、18和24小时采集血样。采用高效液相色谱-质谱法测定曲唑酮血药浓度。一组8只兔子配备了加速度计(活动)并记录了视频。他们随机接受三种治疗中的一种:口服曲唑酮(20 mg kg-1; TRAZ),安慰剂(玉米油基;placc)或不治疗(CONTR),治疗之间有3天的洗脱期。10小时(0-2、2-4、4-6、6-8和8-10小时)评估探索、梳理、休息、警戒、躲藏和摄食行为。结果:治疗后0.3±0.11 h血药浓度平均最高为6592.6±586.5 ng mL-1。平均半衰期为3.24±0.36小时,曲线下面积为25,412.5±5420.9 ng mL-1 hour-1。在0-2小时,TRAZ和placc的活性高于contrr, TRAZ探索更多。与对照组(0-2小时和4-6小时)和对照组(0-6小时)相比,TRAZ组的隐藏程度有所降低。与plac2 -4小时和contr4 -6小时相比,TRAZ的静息时间增加;2-4小时的休息时间少于8-10小时。与对照组相比,TRAZ的警惕性往往较低。在2-4小时内,TRAZ的食物摄入量减少。打扮随着时间的推移而变化。结论及临床意义:治疗后2-4小时,曲唑酮治疗的动物活性降低,躲藏更少,休息时间更长,食物摄入量减少。
{"title":"Pharmacokinetics and behavioural effects of a single oral dose of trazodone in rabbits","authors":"Adalaïs Gibert , Ryota Watanabe , Marta Garbin , Tristan Juette , Francis Beaudry , Marion Desmarchelier , Inga-Catalina Cruz Benedetti","doi":"10.1016/j.vaa.2025.06.006","DOIUrl":"10.1016/j.vaa.2025.06.006","url":null,"abstract":"<div><h3>Objective</h3><div>To evaluate the pharmacokinetics and pharmacodynamics of a single oral dose of trazodone in laboratory rabbits.</div></div><div><h3>Study design</h3><div>Randomised, blinded, Latin-square study.</div></div><div><h3>Animals</h3><div>A group of eight healthy, juvenile, female New Zealand White rabbits.</div></div><div><h3>Methods</h3><div>Auricular venous catheters were placed in six rabbits before oral trazodone (20 mg kg<sup>–1</sup>) administration. Blood was sampled immediately before and at 15 and 30 minutes and 1, 2, 4, 8, 12, 18 and 24 hours after treatment. Trazodone plasma concentrations were determined using high-performance liquid chromatography–mass spectrometry. A group of eight rabbits were equipped with accelerometers (activity) and video recorded. They randomly received one of three treatments: oral trazodone (20 mg kg<sup>–1</sup>; TRAZ), placebo (corn oil base; PLAC) or no treatment (CONTR) with a 3 day washout period between treatments. Exploring, grooming, resting, vigilance, hiding and ingesting behaviours were evaluated for 10 hours (0–2, 2–4, 4–6, 6–8 and 8–10 hours).</div></div><div><h3>Results</h3><div>Mean maximum plasma concentration, 6592.6 ± 586.5 ng mL<sup>–1</sup>, was 0.3 ± 0.11 hours after treatment. Mean half-life was 3.24 ± 0.36 hours and area under the curve from zero to infinity 25,412.5 ± 5420.9 ng mL<sup>–1</sup> hour<sup>–1</sup>. Activity was higher in TRAZ and PLAC than CONTR at 0–2 hours, with TRAZ exploring more. Hiding was reduced in TRAZ <em>versus</em> CONTR (0–2 hours and 4–6 hours) and <em>versus</em> PLAC (0–6 hours). Resting increased in TRAZ <em>versus</em> PLAC (2–4 hours) and CONTR (4–6 hours); PLAC rested less at 2–4 hours than at 8–10 hours. Vigilance tended to be lower in TRAZ <em>versus</em> CONTR. Food intake decreased in TRAZ at 2–4 hours. Grooming varied over time.</div></div><div><h3>Conclusions and clinical relevance</h3><div>Trazodone-treated animals showed reduced activity, less hiding and more resting than PLAC and decreased food intake 2–4 hours post-treatment.</div></div>","PeriodicalId":23626,"journal":{"name":"Veterinary anaesthesia and analgesia","volume":"52 6","pages":"Pages 821-830"},"PeriodicalIF":1.9,"publicationDate":"2025-06-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145041414","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}